๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High levels of hepatocyte growth factor/scatter factor in diffuse-type bronchioloalveolar cell carcinoma

โœ Scribed by Jun-ichi Yamashita; Michio Ogawa; Shogo Nakano; Kazutoshi Okabe; Michio Abe; Akinori Iwasaki; Motohisa Kuwahara; Yasuteru Yoshinaga; Takayuki Shirakusa


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
327 KB
Volume
83
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


BACKGROUND.

Hepatocyte growth factor/scatter factor (HGF/SF) is a potent mitogen for various neoplastic cells, including neoplastic bronchial epithelia.

METHODS.

Immunoreactive hepatocyte growth factor/scatter factor (HGF/SF) was measured in extracts prepared from 129 nonsmall cell lung carcinoma (NSCLC) specimens, using an enzyme-linked immunosorbent assay. These specimens represented 5 cases of solitary/localized bronchioloalveolar cell carcinoma (BAC), 4 cases of diffuse/infiltrative BAC, 90 cases of non-BAC adenocarcinoma, 25 cases of squamous cell carcinoma, and 5 cases of large cell carcinoma.

RESULTS.

The mean concentration of immunoreactive HGF/SF was more than 19-fold higher in tissue extracts from diffuse-type BAC (265.0 ฯฎ 110.2 ng/100 mg protein) than in those from solitary-type BAC (13.9 ฯฎ 15.9, P ฯฝ 0.005), non-BAC adenocarcinoma (13.8 ฯฎ 14.9, P ฯฝ 0.001), squamous cell carcinoma (13.2 ฯฎ 14.4, P ฯฝ 0.001), or large cell carcinoma (11.2 ฯฎ 6.5, P ฯฝ 0.005). When immunohistochemical staining for HGF/SF was performed, intense HGF/SF staining was uniformly observed in diffuse-type BAC tumor cells, but not in solitary-type BAC.

CONCLUSIONS.

Although BAC is included as a subtype of adenocarcinoma in the World Health Organization classification, diffuse-type BAC should be considered a distinct biologic entity, at least in terms of HGF/SF expression, from solitary-type BAC or non-BAC adenocarcinoma. In addition, the solitary and diffuse forms of BAC are known to be associated with different prognoses; for the latter, the prognosis is much poorer than for the former. The results of this study may at least partly explain this difference in prognosis.


๐Ÿ“œ SIMILAR VOLUMES


Levels of vascular endothelial growth fa
โœ Nils Ole Schmidt; Manfred Westphal; Christian Hagel; Sรผleyman Ergรผn; Dimitrios S ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 288 KB ๐Ÿ‘ 1 views

Angiogenesis is a possible target in the treatment of human gliomas. To evaluate the role of 3 growth factors, vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF) and basic fibroblast growth factor (bFGF), in the angiogenic cascade, we determined their levels

Induction of hepatocyte growth factor/sc
โœ Eiichi Gohda; Takahiro Takebe; Tomohiro Sotani; Shuji Nakamura; Jun Minowada; It ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 227 KB ๐Ÿ‘ 1 views

Induction of hepatocyte growth factor/scatter factor (HGF/SF) may be one of the critical steps in organ regeneration, wound healing, and embryogenesis. We previously reported the production of HGF/SF from various human leukemia cell lines and a high level of the growth factor in blood and bone marro

Hepatocyte growth factor/scatter factor
โœ Dario Rusciano; Patrizia Lorenzoni; Shuo Lin; Max M. Burger ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 286 KB

Reiterated selection in vivo of B16 murine melanoma cells for enhanced liver metastatic ability yielded a cell line (B16-LS9) dramatically overexpressing a constitutively active hepatocyte growth factor/scatter factor (HGF/SF) receptor, the product of the c-met proto-oncogene. Most likely because of

Hepatocyte growth factor stimulates moti
โœ Anthony N. Corps; Heidi M. Sowter; Stephen K. Smith ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 150 KB ๐Ÿ‘ 2 views

A proportion of ovarian carcinomas markedly overexpress the proto-oncogene c-met, which encodes the receptor for hepatocyte growth factor (HGF). HGF may either stimulate or inhibit the multiplication of its target cells, and may also promote motogenesis and morphogenesis. In this study, we establish

Hepatocyte growth factor (HGF) in ovaria
โœ Heidi M. Sowter; Anthony N. Corps; Stephen K. Smith ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 180 KB ๐Ÿ‘ 2 views

Hepatocyte growth factor (HGF) is a pleiotropic growth factor implicated in the growth and spread of some epithelial tumours. The epithelial cells of a proportion of ovarian tumours, and some ovarian carcinoma cell lines, express high levels of the HGF receptor, c-Met. In this study, we show that ov

Hepatocyte growth factor/scatter factor
โœ Wen G. Jiang; Tracey A. Martin; Kunio Matsumoto; Toshikazu Nakamura; Robert E. M ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 300 KB ๐Ÿ‘ 2 views

Hepatocyte growth factor/scatter factor (HGF/SF), a multi function cytokine has been shown to regulate the expression of cell adhesion molecules in endothelial cells. In the current study, we examined the effects of HGF/SF on the function of tight junctions and the expression of occludin in these ce